FormulaSignalCheck the Record

Permanent product Record

NUTRABIO

Bloodline

CURRENTRecord last observed August 3, 2026

NutraBio Bloodline has a current Record. Last observed August 3, 2026. The current public formula contains 9 declared ingredient lines. Comparable formula history is not yet available.

Current Record

The current declared formula.

Printed label wording stays separate from FormulaSignal's normalized identity. Current formula observed August 3, 2026.

Serving size
Not recorded
Servings
Not recorded
Caffeine
Not computable from current evidence
Formula scope
FLAVOR SPECIFIC
Original label wordingDeclared amountNormalized identity
Vitamin C (as ascorbic acid)250 mgvitamin c
Sodium (as Himalayan pink salt and sodium citrate)200 mgsodium
L-Citrulline8 gl-citrulline
HydroPrime (65% glycerol powder)3 ghydroprime 65% glycerol powder
Betaine Anhydrous (trimethylglycine)2.5 gbetaine anhydrous
VasoDrive-AP [isoleucyl-prolyl-proline (IPP) and valyl-propyl-proline (VPP) isolated from hydrolyzed milk casein]508 mgvasodrive-ap isoleucyl-prolyl-proline ipp and valyl-propyl-proline vpp isolated from hydrolyzed milk casein
PeptiPump [lentil (Lens culinaris) protein hydrolysate]200 mgpeptipump lentil lens culinaris protein hydrolysate
Pine Bark Extract (Pinus massoniana lamb, 170 mg proanthocyanidins)200 mgpine bark extract pinus massoniana lamb 170 mg proanthocyanidins
AstraGin [Astragalus membranaceus (root), Panax notoginseng (root)]50 mgastragalus and panax extract blend

Serving economics

Facts and calculations stay labeled.

Captured commercial fact
Observed price, basis not established: $44.99
Price observation
August 3, 2026
Captured commercial serving count
20 servings per container
Deterministic calculation
$44.99 ÷ 20 = $2.25 per serving

Historical timeline

Comparable formula states.

Dates below are observation dates. They are not exact reformulation dates.

Historical formula evidence is not yet sufficient for a reliable comparison. This does not establish that the product never changed.

Confirmed Signals

Reviewed changes in the public Record.

No confirmed public Signal is associated with this product. This is not a claim that the product never changed.

Research-dose context

Selected evidence, not a universal effective dose.

These comparisons retain the studied protocol, source, and limitations. They do not establish safety, effectiveness, or a dose recommendation for this product.

A1

L-citrulline

Product declaration
L-Citrulline: 8 g
Selected studied range
3000 to 9000 mg
Protocol and duration
per day, in the studies NIH ODS summarizes
Studied context
Studied as a nitric-oxide pathway precursor (converted to arginine via the urea cycle) for aerobic exercise performance measures such as oxygen-uptake (VO2) kinetics, blood lactate, and rate of perceived exertion, and for acute resistance-exercise performance and muscle oxygenation. NIH ODS describes evidence for enhancing performance as limited, with few studies and conflicting results.
Limitations
A 2022 systematic review/meta-analysis found no significant benefit for endurance-performance outcomes specifically. A single 8 g acute dose did not enhance isometric force production, muscle endurance, or muscle-oxygenation parameters in one resistance-exercise study. NIH ODS characterizes overall performance-enhancement evidence as limited.

Selected evidence: NIH ODS, Dietary Supplements for Exercise and Athletic Performance · Open source

A1

Betaine anhydrous

Product declaration
Betaine Anhydrous (trimethylglycine): 2.5 g
Selected studied range
2000 to 5000 mg
Protocol and duration
per day, studied for up to 15 days
Studied context
NIH ODS describes betaine as studied for strength- and power-based performance in bodybuilders and cyclists, with "potential but modest" improvements from a limited set of small, sometimes conflicting studies. A 2024/2025 systematic review focused specifically on endurance performance (VO2max, time-to-exhaustion, time-to-completion, power output).
Limitations
The endurance systematic review explicitly states "limited and inconclusive evidence regarding the definitive ergogenic effect of betaine supplementation on endurance exercise performance". Only 2 of 5 reviewed studies showed a significant improvement, and the authors call for "additional, more rigorous research."

Selected evidence: NIH ODS, Dietary Supplements for Exercise and Athletic Performance · Open source

Cautions and regulatory records

A filing and a documented risk are not the same thing.

These attach to declared ingredients, not to this product as a whole. Nothing here establishes that the product is safe or unsafe. Talk with a qualified health professional.

No documented caution is recorded against the declared ingredients on this Record. That is not a finding that the product is safe.

Where the sources disagree

What we could not read cleanly.

A disagreement between sources is recorded rather than smoothed into one confident number. None of these is a Signal.

No source conflict is recorded on this Record. That is not a claim that every source agrees, only that none we read disagreed.

Evidence

Audit the material claims.

  • NutraBio

    P1 current formula source · observed August 3, 2026 · accessed August 3, 2026

    Open source evidence

  • NutraBio

    P1 commercial capture · observed August 3, 2026 · accessed August 3, 2026

    Open source evidence

Go deeper

Ask now, or keep watch.

Ask about BloodlineWhat changed?Compare doses with selected researchWatch this product in Pro

No released consumer report is available for this product. Browse Reports.